Index of reports
> Cases with Dyspnoea (8)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Amphotericin B where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Amphotericin B side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-11
Patient: 43 year old male
Reactions: Liver Injury, Bronchopulmonary Aspergillosis, Dyspnoea, Haemoptysis, Device Related Infection, Death, Renal Failure, Sepsis Syndrome, Renal Impairment, Cardio-Respiratory Arrest, Cardiac Failure, Respiratory Failure, Hallucination, Visual, Neutropenia, Mycobacterium Fortuitum Infection, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ciprofloxacin HCL
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Clarithromycin
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Oseltamivir
Dosage: 75 mg, 2x/day
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Immunosuppression
Amphotericin B
Indication: Aspergillosis
Prednisolone
Dosage: 60 mg, unk
Indication: Immunosuppression
Ciprofloxacin HCL
Dosage: 60 mg
Voriconazole
Dosage: unk
Indication: Aspergillosis
Teicoplanin
Dosage: 400 mg, 1x/day
Indication: Product Used FOR Unknown Indication
Meropenem
Dosage: 1 g, 2x/day
Indication: Product Used FOR Unknown Indication
Possible Amphotericin B side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-05
Patient: 43 year old male
Reactions: Liver Injury, Right Ventricular Failure, Dyspnoea, Haemoptysis, Cholestasis, Cardio-Respiratory Arrest, Sepsis Syndrome, Respiratory Failure, Aspergillosis, Neutropenia, Mycobacterium Fortuitum Infection, Renal Failure Acute, Influenza A Virus Test Positive
Adverse event resulted in: death
Drug(s) suspected as cause:
Prednisolone
Dosage: 60 mg, daily
Administration route: Oral
Indication: Renal Vasculitis
Ciprofloxacin HCL
Dosage: 500 mg, bid
Indication: Mycobacterium Fortuitum Infection
Meropenem
Dosage: 1 g, bid
Indication: Sepsis Syndrome
Amikacin
Indication: Mycobacterium Fortuitum Infection
Amphotericin B
Indication: Aspergillosis
Prednisolone
Indication: Pulmonary Vasculitis
Voriconazole
Dosage: unk
Indication: Aspergillosis
Cyclophosphamide
Indication: Pulmonary Vasculitis
Oseltamivir
Dosage: 75 mg, bid
Indication: Sepsis Syndrome
Clarithromycin
Dosage: 500 mg, bid
Indication: Mycobacterium Fortuitum Infection
Teicoplanin
Dosage: 400 mg, daily
Indication: Sepsis Syndrome
Cyclophosphamide
Dosage: 100 mg, daily
Administration route: Oral
Indication: Renal Vasculitis
Possible Amphotericin B side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-30
Patient: 43 year old male
Reactions: Liver Injury, Device Related Infection, Death, Cardio-Respiratory Arrest, Mycobacterium Fortuitum Infection, Bronchopulmonary Aspergillosis, Dyspnoea, Haemoptysis, Sepsis Syndrome, Renal Failure, Renal Impairment, Cardiac Failure, Hallucination, Visual, Respiratory Failure, Neutropenia, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ciprofloxacin HCL
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Prednisolone
Dosage: 60 mg, unk
Indication: Immunosuppression
Oseltamivir
Indication: Product Used FOR Unknown Indication
Teicoplanin
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Immunosuppression
Clarithromycin
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Voriconazole
Dosage: unk
Indication: Aspergillosis
Meropenem
Indication: Product Used FOR Unknown Indication
Amphotericin B
Indication: Aspergillosis
Possible Amphotericin B side effects in 47 year old male
Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-04-13
Patient: 47 year old male
Reactions: Respiratory Tract Haemorrhage, Mouth Ulceration, Pyrexia, Hypokalaemia, Weight Increased, Hepatomegaly, Proteinuria, Haemoglobinuria, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Blood Urea Increased, Urine Output Decreased, Haematuria, Diarrhoea, Oral Disorder, Oliguria, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluconazole
Dosage: 200 mg, qd
Administration route: Oral
Tretinoin
Administration route: Oral
Amphotericin B
Dosage: 30 mg, qd
Cefepime
Dosage: 2 g, qd
Indication: Febrile Neutropenia
Other drugs received by patient: Meropenem; Mitoxantrone; Cytarabine; Dipyrone TAB; Dexamethasone
Possible Amphotericin B side effects in 47 year old female
Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-03-08
Patient: 47 year old female, weighing 68.8 kg (151.4 pounds)
Reactions: Tachycardia, Hypokalaemia, Weight Increased, Hepatomegaly, Bronchospasm, Thrombocytopenia, Renal Failure Acute, Dyspnoea, Pneumonia, Mouth Haemorrhage, Anaemia, Pulmonary Haemorrhage, Urethral Haemorrhage, Retinoic Acid Syndrome, Renal Impairment, Diarrhoea, Respiratory Failure, Oliguria, Asthenia, Leukopenia, Infusion Related Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluconazole
Dosage: 200 mg/day orally
Administration route: Oral
Indication: Candidiasis
Cytarabine
Dosage: 370 mg/m2/day ev, for 7 days
Cefepime
Dosage: 2 g every eight hours as empiric therapy, intravenous
Indication: Febrile Neutropenia
Dipyrone INJ
Dosage: 500 mg orally
Administration route: Oral
Indication: Febrile Neutropenia
ALL Transretinoic Acid (All Transretinoic Acid)
Dosage: 40 mg/m2/day orally, 20 mg/m2/day orally
Administration route: Oral
Indication: Chemotherapy
Amphotericin B
Dosage: 30 mg/day (6 hours of infusion), 240 mg (cumulative dose)
Indication: Candidiasis
Mitoxantrone
Dosage: 20 mg/m2/day ev, for 3 days
Indication: Chemotherapy
Meropenem
Dosage: 1 g ev, every eight hours
Possible Amphotericin B side effects in 47 year old female
Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-03-07
Patient: 47 year old female
Reactions: Dyspnoea, Hepatomegaly, Respiratory Tract Haemorrhage, Candidiasis, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Tretinoin
Dosage: unk
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Mitoxantrone
Dosage: unk
Indication: Acute Promyelocytic Leukaemia
Fluconazole
Dosage: 200 mg/day
Administration route: Oral
Indication: Candidiasis
Metamizole
Dosage: unk
Indication: Acute Promyelocytic Leukaemia
Amphotericin B
Dosage: 30 mg/day 6:0
Indication: Product Used FOR Unknown Indication
Cefepime
Dosage: 2 g, every 8:0
Indication: Acute Promyelocytic Leukaemia
Cytarabine
Dosage: unk
Indication: Acute Promyelocytic Leukaemia
Other drugs received by patient: Meropenem; Methotrexate; Tretinoin
Possible Amphotericin B side effects in 47 year old male
Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-03-03
Patient: 47 year old male
Reactions: Respiratory Tract Haemorrhage, Mouth Ulceration, Pyrexia, Hypokalaemia, Weight Increased, Hepatomegaly, Proteinuria, Haemoglobinuria, Blood Creatinine Increased, Renal Failure Acute, Blood Urea Increased, Dyspnoea, Urine Output Decreased, Haematuria, Diarrhoea, Oral Disorder, Oliguria, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amphotericin B
Dosage: 30 mg, qd
Fluconazole
Dosage: 200 mg, qd
Administration route: Oral
Cefepime
Dosage: 2 g, qd
Indication: Febrile Neutropenia
Tretinoin
Administration route: Oral
Other drugs received by patient: Dipyrone TAB; Mitoxantrone; Cytarabine; Meropenem; Dexamethasone
Possible Amphotericin B side effects in 34 year old female
Reported by a health professional (non-physician/pharmacist) from Brazil on 2011-11-18
Patient: 34 year old female, weighing 56.0 kg (123.2 pounds)
Reactions: Hyperpyrexia, Bronchopneumonia, Wheezing, Pyrexia, Multi-Organ Failure, Oral Candidiasis, Pulmonary Congestion, Cough, Renal Failure Acute, Oxygen Saturation Decreased, Dyspnoea, Metabolic Acidosis, Maternal Exposure During Pregnancy, Respiratory Distress, Cardiogenic Shock, Agranulocytosis, Fungal Infection, Oliguria, Systemic Inflammatory Response Syndrome, Neutropenia, Fusarium Infection, Septic Shock, Leukopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Nitrofurantoin
Indication: Infection Prophylaxis
Ganciclovir
Indication: Fusarium Infection
Nystatin
Administration route: Oral
Indication: Fusarium Infection
Amphotericin B
Ceftriaxone
Nystatin
Administration route: Oral
Metamizole Sodium
Indication: Tracheobronchitis
Ceftriaxone
Indication: Pyelonephritis
Ceftriaxone
Indication: Tracheobronchitis
Ceftriaxone
Clarithromycin
Indication: Fusarium Infection
Imipenem
Indication: Tracheobronchitis
Imipenem
Propranolol HCL
Indication: Mitral Valve Stenosis
Furosemide
Indication: Pulmonary Congestion
Nystatin
Administration route: Oral
Indication: Tracheobronchitis
Imipenem
Indication: Fusarium Infection
Ganciclovir
Vancomycin
Indication: Tracheobronchitis
Clarithromycin
Indication: Tracheobronchitis
Vancomycin
Clarithromycin
Ganciclovir
Indication: Tracheobronchitis
Vancomycin
Indication: Fusarium Infection
Amphotericin B
Indication: Tracheobronchitis
Amphotericin B
Indication: Fusarium Infection
Other drugs received by patient: Oxytocin; Dobutamine HCL; Vitamin TAB; Sodium Chloride; Nitric Oxide
|